Detection of unknown single nucleotide polymorphism (SNP) relies on large scale sequencing expeditions of genomic fragments or complex high-throughput chip technology. We describe a simplified strategy for fluorimetric detection of known and unknown SNP by proportional hybridization to oligonucleotide arrays based on optimization of the established principle of signal loss or gain that requires a drastically reduced number of matched or mismatched probes. The array consists of two sets of 18-mer oligonucleotide probes. One set includes overlapping oligos with 4-nucleotide tiling representing an arbitrarily selected "consensus" sequence (consensusoligos), the other includes oligos specific for known SNP within the same genomic region (variantoligos). Fluorescence-labeled DNA amplified from a homozygous source identical to the consensus represents the reference target and is co-hybridized with a differentially-labeled test sample. Lack of hybridization of the test sample to consensus-with simultaneous hybridization to variant-oligos designates a known allele. Lack of hybridization to consensus-and variant-oligos indicates a new allele. Detection of unknown variants in heterozygous samples depends upon fluorimetric analysis of signal intensity based on the principle that homozygous samples generate twice the amount of signal. This method can identify unknown SNP in heterozygous conditions with a sensitivity of 82% and specificity of 90%. This strategy should dramatically increase the efficiency of SNP detection throughout the human genome and will decrease the cost and complexity of applying genomic wide analysis in the context of clinical trials.
Background
The human genome project provides the first reference sequence of all human chromosomes with the remaining challenge of characterizing the frequency of deviations from this reference among individuals [1] . It is estimated that 1.42 million SNP are distributed throughout the human genome and about 60,000 SNP fall within exons [2] . Detection of SNP due to genetic variation in a given population (polymorphisms) or epigenetic changes throughout life (mutations) is important since it often has functional implications. In fact, 25 % of the known nonsynonymous SNP could affect the function of the correspondent gene product [3] [4] [5] [6] . Yet, it is still unclear whether the prevalence of common diseases can be truly attributed, at least in part, to SNP because of the incomplete information available about SNP prevalence throughout the genome. The completion of the human genome project could not provide comprehensive knowledge about sequence variations because sequences are based on information derived from randomly chosen individuals [1, 2] and there are only few examples of systematic searches for genetic variants within a specific genomic region [7] . However, in the context of clinical research a large number of individuals may need to be screened when investigating associations between genetic variation and disease susceptibility. In such an endeavor, a tool capable of efficiently identifying known and flagging unknown SNP could dramatically increase the efficiency of the study of human pathology through direct application of genome-derived information [8] .
Known SNP can be readily detected using oligo-arraybased techniques [9] [10] [11] [12] or comparable high-throughput systems [13] - [14, 15] . Detection of unknown SNP, however, is not as readily achievable because most current methodologies are based on the utilization of probes encompassing only known variant sequences [16, 17] . Thus, identification of unknown SNP has relied on highthroughput sequencing which is burdened by high cost and demanding requirements for sample preparation. To improve the efficiency of SNP detection, high-density oligonucleotide arrays have been proposed that cover all possible sequence permutations of the genomic region of interest [7, 9, 18, 19] . These arrays are characterized by extreme accuracy not only for detecting but also in providing definitive sequence information about SNP [9] . However, for each genomic region a complex SNP array needs to be assembled as for the 4L (length of nucleotide) oligomer probes [9] . These arrays are composed of oligomer probes that query sequential positions in the genome spanning the length of the probe each one overlapping the previous one of one base. For each position a set of four oligos is prepared identical except at a single, generally central, position systematically substituted with each of the four nucleotides. Thus for a given genomic region a number of oligos equal to the number of bp investigated times 4 is spotted to the array. To query a 16,569-base pairs (bp) sequence 66,276 probes were necessary [9] . Similarly others have investigated BRCA1 and ATM genes using 96,600 and >90,000 oligonucleotides for genomic regions encompassing 3,450 and 9,170 bp respectively [10, 19] . Although this approach could potentially cover the full genome, it might not be justified for genomic areas with no polymorphism [9] . In addition, preparation of these arrays would be disproportionate for genomic areas with very low density of SNP. In those cases it would be preferable to obtain more information about the location of highly polymorphic sites prior to the design of 4L tiled arrays or other comprehensive high-throughput systems. Finally, this approach would not be justifiable in situation where SNP occur extremely rarely in a given population. In those cases a tool that could identify the rare individuals carrying SNP could indicate few instances where routine sequencing of a limited genomic region could be more appropriate than the preparation of complex high-density arrays. Thus, a simplified screening tool that could discriminate conserved from polymorphic genomic regions or identify rare individuals carrying unusual SNP could dramatically restrict the use of highthroughput sequencing or guide the production of highdensity 4L tiled arrays.
Results
We describe here a strategy that utilizes the well-established principle of loss or gain of hybridization signal [9, 19] . for the screening of genomic regions that requires 250 overlapping oligos to cover a 1 kb consensus sequence (consensus oligos) or 4,142 rather than 66,276 oligos to cover a 16.569 bp genomic region as for the previous example [9] . Thus, the proposed strategy should be considered a screening tool applicable for the investigation of unexplored areas of the human genome prior to extensive sequencing expeditions or the construction of high-density arrays. In addition, in situations where allelic variation is already revealed, the array can be complemented by a number of oligos equal to the number of known SNP within that region. This number, therefore, is proportional to the degree of pre-documented polymorphism of a given genomic fragment. This strategy proposes a fluorimetric detection of SNP by proportional hybridization to oligonucleotide arrays. The reference sample, from a homozygous cell line identical to the consensus (a,a), and test sample are amplified by PCR followed by in vitro transcription to generate single stranded RNA. Array data generated from hybridization of fluorescence-labeled reference (i.e. Cy3, green) and test (i.e. Cy5, red) cDNA sample to consensus and additional oligos, representing known SNP (variant oligos), is compared and represented as natural log of the fluorescence intensity ratio ( Log Ratio). In diploid organisms, four type of combinations can occur: I) Homozygosity identical to the consensus (a,a); II) Homozygosity different from the consensus (b,b); III) heterozygosity containing one allele identical and one different from the consensus (a,b); IV) heterozygosity with both alleles different from the consensus (b,c). Although this conceptually applies to whole genes, in loci containing more than one polymorphic site, this distinction applies to regions investigated by individual oligos; while, for the whole gene various combinations can simultaneously occur. Thus, in this paper we will refer to the various combinations by specifying ad hoc whether we are referring to the whole gene or a specific region of the same gene.
To illustrate this strategy, we selected a region of the human genome spanning exon 2 of the Human Leukocyte Antigen (HLA)-A locus, which contains multiple polymorphic sites (Figure 1 ). This gave us the opportunity to identify different homo-heterozygous combinations using genomic DNA from previously classified HLA-typed Epstein-Barr virus-transformed B lymphoblastoid (EBV) cell lines obtained from the European Collection of Animal Cell Cultures. The HLA type of all cell lines was verified using sequence-based typing methods [20] . According to conventional display, the HLA-A*0101 sequence was chosen as the consensus http://www.antho nynolan.com/HIG/data.html. A set of 75 18-mer oligos with 4-nucleotide tiling were selected to cover the HLA-A*0101 allele from position 71 to 343. In addition, several variant oligos relevant to the HLA phenotype of the EBV lines tested were designed (Figure 2 ) with the SNP in the centermost position to enhance the power of discrimination caused by single nucleotide mismatch. Other known SNP close to the 3' region were not covered by variant oligos to test the capability to detect unknown variants ("unknown SNP" displayed in black in Figure 1 ).
HLA-A Locus, Exon II nucleotide sequence alignment of alleles relevant to the discussion of this manuscript 
-------------------------C--------------------------------------------------------------A*2901 ---------------------------AC--------------------------------------------------------------

-----------------------------------------G------------------------------------T----------A*0205 ---------------------------------------G--G------------------------------------T----------A*0206 ------------------------------------------G------------------------------------T----------A*0210 ------------------------------------------G------------------------------------T----------A*0301 ------------------------------------------G-----------------------------------------------A*2301 ------------------------------------------G-----------------------------------------------A*2901 -------------------T----------------------G---------------A-------------------------------
----GG------------AG--------------------C------T-G---------------------------------------C--A*0205 -----GG------------AG--------------------C------T-G---------------------------------------C--A*0206 -----GG------------AG--------------------C------T-G---------------------------------------C-A*0210 -----GG------------AG--------------------C------T-G---------------------------------------C--A*0301 --------------------G----------G----------------T-G---------------------------------------C--A*2301 -----G--------G----AG---------------------------A-------C---T-GC--T-C---------------------C--A*2901 ------T-C-----------G----------G----------------------------------------------------------C--
A
In case of a,a homozygosity, similar fluorescence intensity is expected in both channels with a theoretical Cy5/Cy3 fluorescence intensity ratio = 1 ( Log Ratio = 0). This can be experimentally tested by arbitrarily selecting genomic fragments within the investigated region that, based on available information, are most likely conserved in every potential test sample (displayed in yellow in Figure 1 ) [2] . In this region, reference and test samples can be predicted to be a,a homozygous. Consistent deflection from 0 of Log Ratios in these oligos denotes biases of labeled target or reference. Thus, the average of the Log Ratio for these oligos is used as a normalization factor, constant (k), to correct the bias of both channels in the rest of the data set. The unlikely occurrence of SNP within the constant region could still be detected since in such cases, the Log Ratio of one oligo will diverge from the rest of the constant region oligos.
After normalization, individual oligos are investigated. Homozygosity (a,a) is characterized by Log Ratio ~0, digitally displayed as yellow in the array image ( Figure 3 , row I). Conversely, in the context of homozygosity different from the consensus (b,b), specific hybridization of the test sample to the variant oligo results in strong red (Cy5) signal (Va 1 in Figure 3 , row II) while the consensus oligo spanning the same region reveals strong green signal caused by hybridization of the reference sample only (Figure 3 , row II). Non-specific low affinity hybridization to an irrelevant variant oligo spanning the same regions is similar for both reference and test sample resulting in fluorescence intensity ratios close to 1 ( Log Ratio ~0) (Va 2 in Figure 3 , row II).
Since human genomes are diploid, polymorphisms can occur in combinations and, therefore, detection of SNP
Variant oligos used in this study
Figure 2
Variant oligos used in this study. Oligos are color coded to correspond to the regions described in Figure 1 . *1-SP-A-02a and 1-SP-A-02b contain one HLA-A*0201-specific mismatch and one additional mismatch (G > A in position 72). should be possible in the context of heterozygosity. This discrimination can be achieved through fluorimetric assessment of the hybridization pattern based on the general principle that homozygous samples (two identical alleles) will generate twice the amount of signal for a given sequence than a heterozygous sample ( Figure 3 , rows III-VII). In the context of heterozygosity, a single allele hybridization to variant oligos generates a weaker signal than in the homozygous condition resulting in a lower Log Ratio (specific hybridization over background). ferentially labeled with Cy5 and Cy3 (Figure 4c ). Good correlation of Cy5 with Cy3 signal intensity was observed based on individual oligo although the kinetics of hybridization varied remarkably among different oligos Figure  4d . In general, the hybridization efficiency correlated to the theoretical expectation that the variant oligos (red in the scatter plot) should have low affinity for HLA-A*0101 targets. However, exceptional variant oligos with strong hybridization affinity to HLA-A*0101 and, conversely, a cluster of consensus oligos (average CG content = 75%, range 67 to 94%) with poor hybridization kinetics (blue in the scatter plot) were noted. Strong hybridization of the reference sample to a variant oligo could be associated with GC rich oligo or a T → A or T → C replacement, while decreased hybridization of reference sample to consensus oligo could be caused by self-annealing of GC rich sequences. These, fluctuations in strength of hybridization had, however, little impact on the analysis, since differential hybridization could still be easily detected when samples from different genotypes were tested (clusterogram in Figure 4d ). For instance, reciprocal labeling in the context of b,b homozygosity or b,c heterozygosity demonstrated perfect symmetry in hybridization to variant and consensus oligos.
Data could be ordered sequentially into genotypic profiles according to sequence position. The a,a homozygosity phenotype was characterized by Log Ratios with minimal deviation from 0 (Figure 5a,5F ). Conversely, b,b homozygosity yielded extremely high Log Ratios in variant oligos and strongly depressed Log Ratio in the corresponding consensus oligos (Figure 5b) . Noteworthy is the pattern of proportional hybridization to the variant oligo p (p = oligo 13-SP-A-02 at position 248-265) that encompasses a double nucleotide variant from CA → GG in position 256-257. The oligo containing this double mismatch further reduced the hybridization affinity to the reference sample, proportionally enhancing the affinity of the test sample leading to higher Log Ratio for oligo p in Figure 5b . The "unknown" SNP (from position 250 to 310) was revealed by absence of variant-specific hybridization but highly depressed Log Ratios of the corresponding consensus region oligos (orange asterisks and dashed line in Figure 5b) . This phenomenon may exemplify the ability of this method to detect allelic variants in the absence of variant-specific oligos. Even in conditions of a,b heterozygosity (Figure 5c ), "unknown" SNP could be suspected due to the relatively reduced Log Ratios (0.5 ~1) in variant oligos and more characteristically less depressed Log Ratios in corresponding consensus oligos compared with b,b homozygosity (Figure 5b) . Noteworthy is the exceptional behavior of the variant oligo p that contains a double nucleotide variant (p in Figure 5c ) which leads to higher Log Ratios even in the context of a,b heterozygosity. However, the corresponding consensus oligos are not affected by the double nucleotide variant and, therefore, display a typical a,b heterozygosity pattern distinguishable from b,b homozygosity since one allele in the test sample is identical to the reference.
Heterozygosity with both alleles different from the consensus (b,c) represents the most complex situation ( Figure  5d ). In this case, heterozygous samples such as A*0201, 2901, Log Ratios behave as in b,b homozygosity at this specific region since both alleles hybridize to the same variant oligo and neither to the correspondent consensus oligos. The discriminatory power of this phenomenon can be better illustrated by comparing the hybridization pattern of the same oligo in conditions of b,b homozygosity (HLA-A*2901 homozygous) and a,b heterozygosity (HLA-A*0101,2901 heterozygous) (x in Figure 6 ). In this case, differential hybridization pattern is marked by doubling and halving of Log Ratios in variant and consensus oligos respectively (see also Table in Figure 6 ). Thus, variable types of heterozygosity in the test sample may affect differently the proportional hybridization to the correspondent consensus oligos. An extreme example occurs when one allele of the test sample hybridizes to the variant oligo (14-SP-A*29; position 263-280) while an unknown SNP is present in the other allele within the same region (HLA-A*0201, y in Figure 5d ). This exemplifies a case of b,c heterozygosity in which one SNP is unknown as theorized in row V, Figure 3 . In this case, a reduced Log Ratio in the variant oligo associated with extremely depressed Log Ratios in the corresponding consensus oligo are observed because both test alleles are different from the consensus. The power of discrimination a,b and b,c heterozygosity in regions with "unknown " SNP is underlined by the dashed line in Figure 5d . The blue line highlights polymorphisms occurring in both alleles (A*0201,2901). Thus, the corresponding consensus oligos display strongly depressed Log Ratios comparable to b,b type homozygosity. In the following region, the dashed orange line indicates polymorphisms occurring only in one allele (A*0201 and not 2901) resulting in less depressed Log Ratios in the corresponding consensus oligos as in the case of a/b heterozygosity.
Occurrence of more than one SNP within an oligo could complicate the data analysis. For instance, in the case described in Figure 5d , two regions with a double mismatch are observed which are characterized by Log Ratios disproportionately high for the HLA-A*0201/2901 heterozygous state (p and q depict oligos 13-SP-A-02 and 3-SP-A-2901 respectively, specific for the two alleles). In conditions of HLA-A*0201/2901 heterozygosity, consensus oligos corresponding to polymorphism p representing A*0201, strongly hybridized to the reference sample resulting in a b,b homozygosity hybridization pattern. In the case of polymorphism q representing A*2901 variant, the same A*0201 region is identical to the consensus and, therefore, a,b heterozygosity pattern is observed.
An unexplainable finding was observed where specific hybridization to a variant oligo is not associated with depressed Log Ratios of the correspondent consensus oligo (z in Figure 5d) . A purposeful mismatch, a C → A switch, may have less repercussions on the hybridization pattern of this oligo. Indeed, even in homozygous conditions (z in Figure 6 ) the Log Ratios are only minimally depressed in this case. In these relatively rare occurrences (only case in our study) an "unknown" polymorphism would not be detected.
Profiling by proportional hybridization of HLA-A exon 2 
B
To statistically assessed the ability of this method to discriminate differences between a,a homozygosity from other combinations in conditions of unknown SNP, we analyzed the behavior of consensus oligos only in various experimental conditions. For each 18-mer probe, starting from 3 rd base and ending at 16 th base, if the test target contained at least one single nucleotide different for the consensus sequence HLA-A*0101, we considered this specific region SNP(+); otherwise it was SNP(-). Various combinations were tested as shown in Figure 7 . In all permutations tested (given appropriate sample size) the set of 4-nucleotide tiling consensus oligo alone demonstrated a high SNP discriminatory power. In particular, even the theoretically most problematic combination (a,b vs a,a), least divergent from the consensus, could be easily significantly discriminated in all permutations tested.
We then tested the sensitivity and specificity of this strategy by examining the relationship between LogRatio and the actual SNP condition via ROC (Relative Operating Characteristics) analysis [21] . The ROC curves in Fig. 5 were composed of 3 different groupings. As it could be expected, optimal threshold for detection of polymorphism related sensitivity and specificity varied according to the allelic combination. When the test sample is most different from the consensus reference as for b,b an b,c Genomic "fingerprinting" using proportional hybridization Figure 6 Genomic "fingerprinting" using proportional hybridization. Description of individual genotype combinations. Four allelic combinations are described here using graphics similar to the ones described in Figure 5 . The data for each allelic combination represent the average Log Ratio ± SDev of three separate tests. In the accompanying Table, higher accuracy with sensitivity 82% and specificity 96% is observed (red line). The worst accuracy was noted when test and reference samples were closest as in the case of a,b heterozygosity (sensitivity 82% and specificity of 82%) (blue line). The most informative analysis was, however, provided using data from all the possible combinations (green line in Figure 8 ) since in most common experimental condition the relationship between test and consensus sample is not known and, therefore, all possible allelic combinations should be expected. In that case an optimal threshold of Log Ratio ≤ -0.62 yielded sensitivity at 82% and specificity at 89%. Thus, this strategy may identify 4 out of 5 SNP with 90% accuracy with the highest chance of discriminating false positive result when an a,b heterozygous sample is tested.
Discussion
In this study, we describe a simplified strategy for the detection of known and unknown SNP that, because of the decreased cost, could be applied to large clinical studies. A flow chart describing the algorithm for the identification of SNP using this method is shown in Figure 9 . Although this strategy was conceived to identify SNP in genes for which little is known about their polymorphism(s), it could also be used for routine typing of known alleles. This could be achieved by preparing allelespecific profiles and matching test results with known permutations collected in databases compiling repeated hybridization profiles as template to eliminate possible false interpretations. Annotation of the test sample genotype will be reported after comparison with established templates. The HLA alleles and corresponding oligos used Degree of discrimination among different HLA alleles using proportional hybridization to oligonucleotide arrays Figure 7 Degree of discrimination among different HLA alleles using proportional hybridization to oligonucleotide arrays. Two sample ttests were used to differences between two means. P-values were calculated for each (a,b) vs. here were selected to exemplify various combinations. Various permutations of homozygosity and heterozygosity can be observed that produce complex hybridization patterns highly specific for a particular phenotype. In these highly polymorphic conditions, each haplotype combination maintains a highly reproducible profile characterized by minimal variance. This allows the creation of "genotypic masks" within narrow ranges of variation to "fingerprint" known haplotype permutations for high-throughput typing of highly polymorphic genes.
We, therefore, describe a potentially powerful and efficient strategy for high-throughput screening of genes for which little is known about their polymorphism. This
Sensitivity and specificity analysis of the strategy Figure 8 Sensitivity and specificity analysis of the strategy. 18-mer probes were assigned to SNP (+) if the sequence of the test channel probe of a specific spot contained at least one single nucleotide different from the sequence A*0101. The other probes were considered SNP(-). ROC (Relative Operating Characteristic) analysis [21] of curves for 3 different allelic combinations. The red line represents a ROC curve generated from 448 spots in 7 b,b homozygosity and b,c heterozygosity experiments with 269 SNP(-) and 179 SNP(+) spots. The blue line represents ROC curves generated from 265 spots in a,b heterozygosity experiments with 169 SNP(-) and 87 SNP(+) spots. The green line represents a ROC curve from 704 spots in all experiments with a total of 438 SNP (-) and 266 SNP (+) spots. The dots on the curves stand for optimal threshold in each group. Threshold for Log Ratio were based on ROC analysis to balance sensitivity and specificity. For the group with b,b and b,c heterozygosity (red line) experiments the optimal threshold was a Log Ratio ≤ -0.91. The sensitivity using this threshold was 82% and specificity 96%. The optimal threshold for the a,b heterozygosity (blue line) was Log Ratio ≤ -0.43 with a sensitivity of 82% but a specificity drop to 82%. For the analysis combined all the data (green line) the optimal threshold was Log Ratio ≤ -0.62 with a sensitivity at 82% and specificity at 89%. This last ROC exemplifies the most common experimental condition where the relationship between test and reference sample is not known and, therefore, all possible allelic combinations should be expected. 
1-Specificity
Sensitivity strategy could also be used to identify mutations in disease processes or for typing known allelic variants of wellcharacterized genes such as HLA. This, however, would require specialized design of numerous oligos encompassing known variants and supportive software for efficient data interpretation. Various scenarios are best exemplified by using as a model a highly polymorphic region of the human genome such as exon 2 of the HLA-A locus. The simplest case would be the investigation of a gene characterized by minimal or no polymorphism. In this case, screening of samples from different ethnic groups would yield a pattern described as a,a type homozygosity, similar to the one shown in Figure 8a . Another possibility would be the investigation of a gene with few but relatively common polymorphism(s). In this case the occurrence of b,b type homozygosity would be common as depicted in Figure 8b . In the same situation, a,b type heterozygosity would also frequently occur as shown in Figure 8c . Finally, a most complex scenario, likely to occur only for genes characterized by high polymorphic prevalence is portrayed in Figure 8d . In this case, b,c type heterozygosity should occur frequently as it might be expected for the HLA loci. However, SNP occur in the human genome on average every 600 -2,000 bases [1, 2] . Therefore, most genes are characterized by a relatively narrow range of polymorphism that would allow a relatively simple design of oligo-array chips and interpretation of results. Independently of the genomic region investigated, this strategy can identify unknown variants through observation of disproportionably depressed Log Ratios in consensus oligos.
Flow chart summarizing the proposed algorithm to screen for known or novel SNP using proportional hybridization to oligonucleotide arrays Figure 9 Flow chart summarizing the proposed algorithm to screen for known or novel SNP using proportional hybridization to oligonucleotide arrays. Cy3-and Cy5-labeled probes were combined (1:1 ratio) and 5 µl 20 × SSC, 0.5 µl 10% SDS and 0.5 µl of 4 mg / ml salmon sperm DNA were added to the probe for hybridization. The samples were then heated for two minutes at 99°C. Prepared probe mixture was applied to an array slide with cover slid and hybridized at 47°C for different amounts of time as described in the text. Slides were washed with 4 × SSC, 2 × SSC with 0.1 % SDS, 1 × SSC, 0.2 × SSC and 0.05 × SSC sequentially for one minute each step and dried by centrifugation at 800 rpm for 3 minutes. The slides were then scanned for fluorescent signal using a GenePix 4000B scanner and the results analyzed using GenePix Pro3 software (Axon Instruments, Inc.).
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